[{"indications": "Indications\u00a0respiratory-tract infections; otitis media; skin and soft-tissue\r\ninfections; uncomplicated gonorrhoea [unlicensed indication], uncomplicated\r\ngenital chlamydial infections and non-gonococcal urethritis (see also\r\nTable 1, section 5.1); mild or moderate typhoid due\r\nto multiple-antibacterial-resistant organisms [unlicensed indication];\r\nLyme disease (see also section 5.1.1.3 [unlicensed indication]); prophylaxis\r\nof group A streptococcal infection (Table 2, section 5.1)", "name": "AZITHROMYCIN - MACROLIDES", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.5 Macrolides"], "cautions": "Cautions\u00a0\n(From 5.1.5 Macrolides: British National Formulary)\nOral infections\u00a0The macrolides are an alternative for oral infections in penicillin-allergic patients or where a beta-lactamase producing organism is involved. However, many organisms are now resistant to macrolides or rapidly develop resistance; their use should therefore be limited to short courses. Metronidazole (section 5.1.11) may be preferred as an alternative to a penicillin.Cautions\u00a0Macrolides should be used with caution in patients with a predisposition to QT interval prolongation (including electrolyte disturbances and concomitant use of drugs that prolong the QT interval). Macrolides may aggravate myasthenia gravis. ; interactions: Appendix 1 (macrolides)", "side-effects": "Side-effects\u00a0\n(From 5.1.5 Macrolides: British National Formulary)\nSide-effects\u00a0Nausea, vomiting, abdominal discomfort, and diarrhoea are the most common side-effects of the macrolides, but they are mild and less frequent with azithromycin and clarithromycin than with erythromycin. Hepatotoxicity (including cholestatic jaundice) and rash occur less frequently. Other side-effects reported rarely or very rarely include pancreatitis, antibiotic-associated colitis, QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Generally reversible hearing loss (sometimes with tinnitus) has been reported after large doses of a macrolide; it occurs commonly after long-term therapy with azithromycin. Intravenous infusion may cause local tenderness and phlebitis.; also\r\nanorexia, dyspepsia, flatulence, dizziness, headache, malaise, paraesthesia,\r\narthralgia, disturbances in taste and vision; less commonly constipation, gastritis, chest pain, oedema, anxiety, sleep disturbances,\r\nhypoaesthesia, leucopenia, photosensitivity; rarely agitation; also reported syncope, convulsions, smell disturbances,\r\ninterstitial nephritis, acute renal failure, thrombocytopenia, haemolytic\r\nanaemia, tongue discoloration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3859.htm", "doses": ["500\u00a0mg once daily for 3 days or 500\u00a0mg\r\non first day then 250\u00a0mg once daily for 4 days; child over 6 months 10\u00a0mg/kg once daily for 3 days; or body-weight 15\u201325\u00a0kg, 200\u00a0mg once daily for 3 days; body-weight\r\n26\u201335\u00a0kg, 300\u00a0mg once daily for 3 days; body-weight 36\u201345\u00a0kg, 400\u00a0mg\r\nonce daily for 3 days", "Uncomplicated gonorrhoea [unlicensed indication] (see also Table\r\n1, section 5.1), uncomplicated genital chlamydial\r\ninfections and non-gonococcal urethritis, 1\u00a0g as a single dose", "Lyme disease (see also section 5.1.1.3), typhoid [unlicensed indications],\r\n500\u00a0mg once daily for 7\u201310 days (7 days in typhoid)"], "pregnancy": "Pregnancy\u00a0manufacturers advise use only if adequate alternatives\r\nnot available"}, {"indications": "Indications\u00a0\n(From 11.3.1 Antibacterials: British National Formulary)\n11.3.1 Antibacterials", "name": "AZITHROMYCIN Single use", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.3 Anti-infective eye preparations", "11.3.1 Antibacterials", "AZITHROMYCIN", "Single use"], "side-effects": "Side-effects\u00a0ocular discomfort (including pruritus, burning),\r\nblurred vision", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/217747.htm", "doses": ["Purulent bacterial conjunctivitis, adult and child over 2 years, apply twice\r\ndaily for 3 days; review if no improvement after 3 days", "Trachomatous conjunctivitis, adult and child over 1 year, apply twice\r\ndaily for 3 days; review if no improvement after 3 days", "Name[Azyter\u00ae (Spectrum Thea)  ] Eye drops, azithromycin (as dihydrate) 1.5%, net price 6 \u00d7 0.25-g = \u00a36.99"], "pregnancy": "Pregnancy\u00a0caution\u2014limited information available"}, {"indications": "Indications\u00a0\n(From 11.3.1 Antibacterials: British National Formulary)\n11.3.1 Antibacterials", "name": "AZITHROMYCIN - ANTIBACTERIALS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.3 Anti-infective eye preparations", "11.3.1 Antibacterials", "AZITHROMYCIN"], "side-effects": "Side-effects\u00a0ocular discomfort (including pruritus, burning),\r\nblurred vision", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/217746.htm", "doses": ["Purulent bacterial conjunctivitis, adult and child over 2 years, apply twice\r\ndaily for 3 days; review if no improvement after 3 days", "Trachomatous conjunctivitis, adult and child over 1 year, apply twice\r\ndaily for 3 days; review if no improvement after 3 days"], "pregnancy": "Pregnancy\u00a0caution\u2014limited information available"}, {"indications": "Indications\u00a0respiratory-tract infections; otitis media; skin and soft-tissue\r\ninfections; uncomplicated gonorrhoea [unlicensed indication], uncomplicated\r\ngenital chlamydial infections and non-gonococcal urethritis (see also\r\nTable 1, section 5.1); mild or moderate typhoid due\r\nto multiple-antibacterial-resistant organisms [unlicensed indication];\r\nLyme disease (see also section 5.1.1.3 [unlicensed indication]); prophylaxis\r\nof group A streptococcal infection (Table 2, section 5.1)", "name": "AZITHROMYCIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.5 Macrolides"], "cautions": "Cautions\u00a0\n(From 5.1.5 Macrolides: British National Formulary)\nOral infections\u00a0The macrolides are an alternative for oral infections in penicillin-allergic patients or where a beta-lactamase producing organism is involved. However, many organisms are now resistant to macrolides or rapidly develop resistance; their use should therefore be limited to short courses. Metronidazole (section 5.1.11) may be preferred as an alternative to a penicillin.Cautions\u00a0Macrolides should be used with caution in patients with a predisposition to QT interval prolongation (including electrolyte disturbances and concomitant use of drugs that prolong the QT interval). Macrolides may aggravate myasthenia gravis. ; interactions: Appendix 1 (macrolides)", "side-effects": "Side-effects\u00a0\n(From 5.1.5 Macrolides: British National Formulary)\nSide-effects\u00a0Nausea, vomiting, abdominal discomfort, and diarrhoea are the most common side-effects of the macrolides, but they are mild and less frequent with azithromycin and clarithromycin than with erythromycin. Hepatotoxicity (including cholestatic jaundice) and rash occur less frequently. Other side-effects reported rarely or very rarely include pancreatitis, antibiotic-associated colitis, QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Generally reversible hearing loss (sometimes with tinnitus) has been reported after large doses of a macrolide; it occurs commonly after long-term therapy with azithromycin. Intravenous infusion may cause local tenderness and phlebitis.; also\r\nanorexia, dyspepsia, flatulence, dizziness, headache, malaise, paraesthesia,\r\narthralgia, disturbances in taste and vision; less commonly constipation, gastritis, chest pain, oedema, anxiety, sleep disturbances,\r\nhypoaesthesia, leucopenia, photosensitivity; rarely agitation; also reported syncope, convulsions, smell disturbances,\r\ninterstitial nephritis, acute renal failure, thrombocytopenia, haemolytic\r\nanaemia, tongue discoloration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3859.htm", "doses": ["500\u00a0mg once daily for 3 days or 500\u00a0mg\r\non first day then 250\u00a0mg once daily for 4 days; child over 6 months 10\u00a0mg/kg once daily for 3 days; or body-weight 15\u201325\u00a0kg, 200\u00a0mg once daily for 3 days; body-weight\r\n26\u201335\u00a0kg, 300\u00a0mg once daily for 3 days; body-weight 36\u201345\u00a0kg, 400\u00a0mg\r\nonce daily for 3 days", "Uncomplicated gonorrhoea [unlicensed indication] (see also Table\r\n1, section 5.1), uncomplicated genital chlamydial\r\ninfections and non-gonococcal urethritis, 1\u00a0g as a single dose", "Lyme disease (see also section 5.1.1.3), typhoid [unlicensed indications],\r\n500\u00a0mg once daily for 7\u201310 days (7 days in typhoid)"], "pregnancy": "Pregnancy\u00a0manufacturers advise use only if adequate alternatives\r\nnot available"}]